FDA Inspection
Xttrium Laboratories, Inc.Xttrium Laboratories, Inc. – FDA Inspection, Mar 15, 2018
Record Details
This FDA Inspection record concerns Xttrium Laboratories, Inc., with an inspection on March 15, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e6a7f72a-a50d-407d-829f-53c9e35667d7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1046665
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.113(a)Procedures for non-sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Xttrium Laboratories, Inc.
15| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2026 | Not classified | Chicago District Office | |
| June 18, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xttrium Laboratories, Inc.
- FDA Inspection 1324176 - 2026-06-16
- FDA Inspection 1273417 - 2025-06-18
- FDA Inspection 1234354 - 2024-03-08
- FDA Inspection 1230448 - 2024-02-06
- FDA Inspection 977965 - 2016-07-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.